- Fee assured
- Verified this account
- Multiple sclerosis (MS)
Areas of interest
Dizzyness and Vertigo;
Headache and Facial Pain;
Mobility and gait;
Movement Disorders & Tremor;
Muscle Disorders and Weakness;
Chronic pain management;
Peripheral Nerve Disorders;
Stroke and TIA
Current NHS consultant posts held
Consultant Neurologist with a special interest in multiple sclerosis at Salford Royal Hospital.
Visiting Consultant Neurologist at Stepping Hill Hospital, Stockport.
Honorary Consultant Neurologist at Royal Manchester Children's Hospital.
Multiple sclerosis therapies.
Progressive multiple sclerosis.
Health outcome measurement
QuDoS in MS 2016 - Greater Manchester MS team were winners of Evidence in Practice: using audit, evaluation or research to improve user experience or outcomes of care.
QuDoS in MS 2017 - Greater Manchester MS team were winners of a special award for the MS Nurse Education course run in Salford Royal.
Neurosarcoidosis associated with intracerebral haemorrhage – a challenge in diagnosis and management. Practical Neurology 2018 (in print)
A Subarachnoid Haemorrhage-Specific Outcome Tool. Brain 2018 (in print).
Perampanel in the general population and in people with intellectual disability: Differing responses. Seizure. European Journal of Epilepsy (2017) 49; 30-35
Acute respiratory distress syndrome following alemtuzumab therapy for relapsing multiple sclerosis. Multiple Sclerosis and Related Disorders (2017) 14, 1-3
A tale of the unexpected. Amyloidoma associated with CNS lymphoplasmacytic lymphoma. Journal of the Neurological Sciences 359 (1), 404-408
Successful treatment of giant cell myositis with combined steroids and intravenous immunoglobulin. Practical Neurology 2015;15:456-459
Laughing ‘til it hurts. A curious case report of mirth and migraine. Headache. The Journal of Head and Facial Pain 55 (1): 12/2014.
A community study in Cornwall UK of sudden unexpected death in epilepsy (SUDEP) in a 9-year population sample. Seizure: European Journal of Epilepsy - 13 March 2014
A new variant of the post-malaria neurological syndrome. Journal of the Neurological Sciences 2013; 334 (2013) 183–185.
Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multi-centre cohort. Neurology 2011 August 9, vol. 77 no. 6 573-579.
Melanoma following treatment with Alemtuzumab for Multiple Sclerosis. European Journal of Neurology 2009; April 16 (4) e70-e71.
Campath 1-H treatment in Patients with Aggressive Relapsing Remitting Multiple Sclerosis. Journal of Neurology 2008 Feb;255(2):231-8.
Courses offered to GPs
I regular deliver talks and presentations to GP teams, allied and other health professionals on a number of neurological topics including the management of migraine and other headache syndromes, tremor, restless limb syndrome, pain disorders, multiple sclerosis and Parkinson's disease.
- MD Medicine and Surgery University of Malta 2001
- MRCP Royal College of Physicians of Edinburgh 2004
- PhD Universities of Plymouth and Exeter 2013
- Specialist Certificate Examination in Neurology JRCPTB and Association of British Neurologists 2013
- CCST Neurology Health Education South West 2014
Reference number 6133465
Professional bodies (positions held - last 3 yrs)
- Member General Medical Council (UK) 2005
- Member Malta Medical Council 2001
- Member Medical Defense Union 2018
- Member Royal College of Physicians of Edinburgh 2004
Details of entry to specialist register
- Specialist Registry Neurology, 2014
- BMI The Alexandra Hospital
- 08:00 - 09:30
- 0161 428 3656
- The Wilmslow Hospital
- 08:30 - 12:30
- 07812 212114
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details
Dr Pace's secretary on 07812212114